Adipogen/TIP60 (human) (rec.) (His) (highly active)/AG-40T-0019-C002/2 ?g
重組蛋白
商品編號(hào)
AG-40T-0019-C002
品牌
Adipogen
公司
Adipogen
公司分類
Proteins
Size
2 ?g
商品信息
More Information
Product Details
Synonyms
Histone Acetyltransferase HTATIP; Histone Acetyltransferase KAT5; Lysine Acetyltransferase 5; 60 kDa Tat-interactive Protein
Product Type
Protein
Properties
Source/Host
Sf21 cells
Sequence
Human TIP60 is fused to a His-tag.
Crossreactivity
Human
BIOLOG
ical Activity
100-200ng are required for standard HAT assay.
Purity
≥95% (SDS-PAGE)
Concentration
Lot dependent (0.2-0.5mg/ml)
Formulation
Liquid. In 50mM TRIS-HCl, pH 7.5, containing 100mM sodium chloride, 0.2% NP-40, 50mM imidazole and 10% glycerol.
Other Product Data
UniProt ID Q92993: Tip60 (human)
Shipping and Handling
Shipping
DRY ICE
Short Term Storage
-20°C
Long Term Storage
-80°C
Handling Advice
After opening, prepare aliquots and store at -80°C.
Avoid freeze/thaw cycles.
Use/St
ABI
lity
Stable for at least 6 months after receipt when stored at -80°C.
Documents
MSD
S
Download PDF
Product Specification Sheet
Datasheet
Download PDF
TIP60 is the catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of selected genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex is required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. TIP60 directly acetylates and activates ataxia-telangiectasia mutated (ATM). In case of HIV-1 infection, interaction with the viral Tat protein leads to KAT5 polyubiquitination and targets it to degradation.
Product References
Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65: C. Buerki, et al.; Nucleic Acids Res.
36,
1665 (2008)
Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms: M. Shi, et al.; Oncotarget
7,
22623 (2016)
產(chǎn)品貨號(hào):2140.0